BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> PRODUCTS

BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol

Products	BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol
Company	BD Diagnostic Systems
Item	BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol
Features	BD Persist Plus protective barrier provides a one-step antimicrobial barrier w/minimum of 1% chlorhexidine Up to 7-day antimicrobial effectiveness
Description	BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol
Info	BD Diagnostic Systems Customer Service: (800) 675-0908

Related medicine products :

1. BD Persist™ skin prep single swab
2. BD Persist™ skin prep triple swabs
3. BD Persist Plus protective barrier skin prep triple swabs with chlorhexidine in alcohol
4. BD Persist Plus protective barrier skin prep single swab with chlorhexidine in alcohol

TAG: Persist Plus protective barrier skin preps with chlorhexidine alcohol

Medicine Products:

Gentamicin LB Agar Plates Magnesium Sulfate-10 LB Agar Plates EDTA-0.1 LB Agar

Breaking Medicine News(10 mins):Health News:Novel detection method unmasks circulating breast cancer cells 2 Health News:Novel detection method unmasks circulating breast cancer cells 3 Health News:Study shows how gene action may lead to diabetes prevention, cure 2 Health News:HealthWyse Clinical and Financial Point of Care Software Addresses OASIS-C Regulations and More 2 Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2 Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3 Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4

[0] Novel detection method unmasks circulating breast cancer cells [0] Study shows how gene action may lead to diabetes prevention, cure [0] Many Stroke Survivors Don't Take Lifesaving Meds [0] HealthWyse Clinical and Financial Point of Care Software Addresses OASIS-C Regulations and More [0] Effort to Regenerate Injured Spinal Cords Turns to a New Model

Other Medicine News:Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 2 Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 3 Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 4 Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 5 Health News:Schlafender Hase Releases Text Verification Tool 4.0 2 Health News:Family counseling improves lives of patients and spouses coping with prostate cancer 2 Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 2 Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 3 Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2 Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2 Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3 Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4 Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5 Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6

SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center Schlafender Hase Releases Text Verification Tool 4.0 Family counseling improves lives of patients and spouses coping with prostate cancer Factor key to severity of community-associated methicillin-resistant staph infections identified New Test Criteria Spots Rheumatoid Arthritis Sooner New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis

Breaking Medicine Technology:Negative Pressure Wound Devices Draw FDA Notice, Advice 2 Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2 FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2 FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3 FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 1 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 2 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 3 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 4 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 5 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 6 Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch Stoma Size in Gastric Bypass Patients 50285 1 Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch Stoma Size in Gastric Bypass Patients 50285 2 Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch Stoma Size in Gastric Bypass Patients 50285 3 IU researchers find vibrator use to be common linked to sexual health 50281 1 IU researchers find vibrator use to be common linked to sexual health 50281 2 IU researchers find vibrator use to be common linked to sexual health 50281 3

[0] Negative Pressure Wound Devices Draw FDA Notice, Advice [0] Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline [0] FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology